Very virulent infectious bursal disease virus in Egypt: epidemiology, isolation and immunogenicity of classic vaccine.

Abstract

Infectious bursal disease (IBD) is still a significant threat facing the Egyptian poultry industry. In this study, eight very virulent IBD viruses (vvIBDV), originating from acute IBD outbreaks recorded in lower and upper Egypt, were studied with respect to their ability to replicate in cell culture, antigenicity and immunogenicity of classic vaccine. Six continuous cell lines and one primary cell culture were tested for replication of the vvIBDVs. None of the vvIBDV isolates could be adapted to BGM-70, Vero, BHK, RK-13 or MDBK cell lines or chicken embryo fibroblast cells after six blind passages. Serological typing with three neutralizing monoclonal antibodies showed antigenic variation among vvIBDVs. The immunogenicity induced by graded doses of classic-intermediate vaccine in both IBD-resistant (Mandarah) and susceptible (Gimmizah) Egyptian chickens was investigated. The protection of the tested doses was evaluated by measurement of the serological response and resistance to vvIBDV challenge 10 days post vaccination. Similar antibody responses to the vaccine were generated over a wide (100-fold) dose range. It was concluded that single vaccination, by eye drops, with classic-intermediate vaccine (1 x) could protect chickens against clinical disease and mortality. However, the immune responses generated by 1 x, 10 x or 100 x vaccine doses did not protect against bursal damage following challenge. This finding points to the highly invasive nature of the prevailing vvIBDVs in Egypt.